Pascal Touchon has been appointed CEO, president and board member of Thousand Oaks biotech Atara Biotherapeutics. Touchon has more than 30 years of global biopharmaceutical leadership experience, most recently at Novartis Oncology. He was serving as global head, cell and gene and previously served as global head, strategy, business development, oncology. He has also held…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
